CN101432013B - 抗分泌因子对于治疗高眼压的应用 - Google Patents

抗分泌因子对于治疗高眼压的应用 Download PDF

Info

Publication number
CN101432013B
CN101432013B CN200780014996.XA CN200780014996A CN101432013B CN 101432013 B CN101432013 B CN 101432013B CN 200780014996 A CN200780014996 A CN 200780014996A CN 101432013 B CN101432013 B CN 101432013B
Authority
CN
China
Prior art keywords
antisecretory
iop
pharmaceutical composition
use according
intraocular pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780014996.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101432013A (zh
Inventor
汉斯阿尔内·汉松
斯特凡·朗厄
埃娃·延尼斯歇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANTMANNEN AS-FAKTOR AB
Original Assignee
LANTMANNEN AS-FAKTOR AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANTMANNEN AS-FAKTOR AB filed Critical LANTMANNEN AS-FAKTOR AB
Publication of CN101432013A publication Critical patent/CN101432013A/zh
Application granted granted Critical
Publication of CN101432013B publication Critical patent/CN101432013B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN200780014996.XA 2006-04-27 2007-04-27 抗分泌因子对于治疗高眼压的应用 Expired - Fee Related CN101432013B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE06009328 2006-04-27
SE0600932-8 2006-04-27
SE0600932 2006-04-27
PCT/SE2007/000414 WO2007126364A2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201210058790.XA Division CN102633863B (zh) 2006-04-27 2007-04-27 抗分泌因子对于治疗高眼压的应用

Publications (2)

Publication Number Publication Date
CN101432013A CN101432013A (zh) 2009-05-13
CN101432013B true CN101432013B (zh) 2015-01-07

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200780014996.XA Expired - Fee Related CN101432013B (zh) 2006-04-27 2007-04-27 抗分泌因子对于治疗高眼压的应用
CN201210058790.XA Expired - Fee Related CN102633863B (zh) 2006-04-27 2007-04-27 抗分泌因子对于治疗高眼压的应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201210058790.XA Expired - Fee Related CN102633863B (zh) 2006-04-27 2007-04-27 抗分泌因子对于治疗高眼压的应用

Country Status (18)

Country Link
US (2) US8207296B2 (cg-RX-API-DMAC10.html)
EP (2) EP2015767B1 (cg-RX-API-DMAC10.html)
JP (2) JP5284948B2 (cg-RX-API-DMAC10.html)
KR (1) KR20090040404A (cg-RX-API-DMAC10.html)
CN (2) CN101432013B (cg-RX-API-DMAC10.html)
AU (1) AU2007244004B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0710959B8 (cg-RX-API-DMAC10.html)
CA (2) CA2771087C (cg-RX-API-DMAC10.html)
DK (2) DK2015767T3 (cg-RX-API-DMAC10.html)
ES (2) ES2773945T3 (cg-RX-API-DMAC10.html)
IL (1) IL194773A (cg-RX-API-DMAC10.html)
MX (1) MX2008013769A (cg-RX-API-DMAC10.html)
NZ (2) NZ598426A (cg-RX-API-DMAC10.html)
PL (2) PL2015767T3 (cg-RX-API-DMAC10.html)
RU (1) RU2458703C2 (cg-RX-API-DMAC10.html)
SG (1) SG171602A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007126364A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200809115B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
JP5820277B2 (ja) 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
NZ708860A (en) * 2012-12-20 2016-09-30 Lantmännen As Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
WO2017009004A1 (en) 2015-07-10 2017-01-19 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of af-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
WO2020002464A1 (en) 2018-06-28 2020-01-02 Lantmännen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
CN112770643A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化脱壳燕麦的可消耗产品
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
EP4125984A1 (en) 2020-03-26 2023-02-08 Lantmännen Functional Foods AB A consumable product comprising malted cereals for promoting recovery at physical activity
US20240148709A1 (en) * 2022-11-08 2024-05-09 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders
WO2026099453A1 (en) 2024-11-07 2026-05-15 Lantmännen Medical Ab Af-16 or af-17 for acute treatment of brain oedema in patients with traumatic brain injury

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1208420A (zh) * 1995-08-24 1999-02-17 瑞典农业专利公司 调节病理通透性改变的抑制分泌因子肽
WO2005030246A1 (en) * 2003-09-26 2005-04-07 As-Faktor Ab Novel use of antisecretory factor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
AU5627000A (en) * 1999-06-21 2001-02-05 Inkine Pharmaceutical Company, Inc. Angiocidin: a CYS-SER-VAL-THR-CYS-GLY specific tumor cell adhesion receptor
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
KR20090037992A (ko) * 2006-04-27 2009-04-17 란트만넨 아스-팍토르 아베 항분비 단백질의 추가적 의학 용도
PL2040734T3 (pl) * 2006-04-27 2012-04-30 Lantmaennen As Faktor Ab Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1208420A (zh) * 1995-08-24 1999-02-17 瑞典农业专利公司 调节病理通透性改变的抑制分泌因子肽
WO2005030246A1 (en) * 2003-09-26 2005-04-07 As-Faktor Ab Novel use of antisecretory factor

Also Published As

Publication number Publication date
US20120283191A1 (en) 2012-11-08
WO2007126364A3 (en) 2008-03-06
DK2468292T3 (da) 2020-03-23
BRPI0710959B1 (pt) 2018-11-06
IL194773A0 (en) 2011-08-01
JP5284948B2 (ja) 2013-09-11
CA2650344C (en) 2017-10-31
RU2008146733A (ru) 2010-06-10
CA2771087A1 (en) 2007-11-08
KR20090040404A (ko) 2009-04-24
EP2468292A1 (en) 2012-06-27
PL2015767T3 (pl) 2016-05-31
MX2008013769A (es) 2009-02-03
PL2468292T3 (pl) 2020-08-24
BRPI0710959B8 (pt) 2021-05-25
CN102633863B (zh) 2014-08-06
IL194773A (en) 2015-07-30
CA2771087C (en) 2016-03-15
US8207296B2 (en) 2012-06-26
US9000125B2 (en) 2015-04-07
BRPI0710959A2 (pt) 2012-02-28
EP2468292B1 (en) 2019-12-18
CN102633863A (zh) 2012-08-15
US20090162296A1 (en) 2009-06-25
AU2007244004B2 (en) 2012-02-09
SG171602A1 (en) 2011-06-29
EP2468292B8 (en) 2020-02-26
WO2007126364A2 (en) 2007-11-08
NZ572255A (en) 2012-03-30
AU2007244004A1 (en) 2007-11-08
WO2007126364A8 (en) 2009-07-23
EP2015767A2 (en) 2009-01-21
JP2012153695A (ja) 2012-08-16
ES2561945T3 (es) 2016-03-01
ES2773945T3 (es) 2020-07-15
DK2015767T3 (en) 2016-02-08
NZ598426A (en) 2012-08-31
EP2015767B1 (en) 2016-01-06
ZA200809115B (en) 2009-07-29
RU2458703C2 (ru) 2012-08-20
JP2009535329A (ja) 2009-10-01
CA2650344A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
US8207296B2 (en) Approach to treat intraocular hypertension
US5767079A (en) Method of treating ophthalmic disorders using TGF -β
CN101460187B (zh) 抗分泌蛋白的进一步医疗应用
JP6063401B2 (ja) 脂質ラフトの調節
WO1994001124A1 (en) METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
US10709768B2 (en) Chondrocyte extracellular matrix-derived peptide
JP2009535329A5 (cg-RX-API-DMAC10.html)
CN110869045B (zh) 包含i型胶原及色素上皮衍生因子肽作为有效成分的预防或治疗新生血管性疾病的药物组合物
AU2012201165B2 (en) New approach to treat intraocular hypertension
HK1172553A (en) New peptide having antisecretory activity
HK1172553B (en) New peptide having antisecretory activity
US20250296965A1 (en) Use of recombinant transforming growth factor beta induced (tgfbi) protein in lattice corneal dystrophy (lcd)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150107

Termination date: 20210427

CF01 Termination of patent right due to non-payment of annual fee